M. Farhan Ali, MD, FAAP

Dr. Ali is committed to providing excellent patient and family-centered nephrology care to the communities in and around Austin. He sees children with all types of kidney conditions including but not limited to congenital anomalies of the kidneys and urinary tract, nephrotic syndrome, glomerulonephritis, acute kidney injury, chronic kidney disease, end-stage kidney disease, kidney stones and pediatric hypertension.

Prior to joining Texas Children’s, Dr. Ali worked as faculty with Children's Mercy Kansas City, providing much needed specialized care at its Wichita, KS location. He also served as medical director of pediatric dialysis at Wesley Children's Hospital, also in Wichita. He is board-certified in Pediatric Nephrology and General Pediatrics.

Personal Statement

My goal is to provide compassionate, collaborative and high-quality care to all my patients.

Clinical Interests

Acute kidney injury, renal replacement therapy, chronic hemodialysis, nephrotic syndrome

Education

Organizations

Board Certifications

American Board of Pediatrics, FAAP

Pediatric Nephrology and General Pediatrics

Honors and awards

2021

Outstanding Teaching Award: KU Wichita Pediatrics, The University of Kansas

2021

Volunteer Faculty Award: KU Wichita Pediatrics, The University of Kansas

2021

Excellence in Health Care-Pediatric Care, Wichita Business Journal

* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.

Research interests

Neonatal AKI

Srivastava T, Garola RE, Zhou J, Boinpelly VC, Priya L, Ali MF, Rezaiekhaligh MH, Heruth DP, Novak J, Alon US, Joshi T, Jiang Y, McCarthy ET, Savin VJ, Johnson ML, Sharma R, Sharma M. Prostanoid receptors in hyperfiltration-mediated glomerular injury: Novel agonists and antagonists reveal opposing roles for EP2 and EP4 receptors. FASEB Journal. 2022 Oct;36(10):e22559. doi: 10.1096/fj.202200875R. PMID: 36125047

Umscheid JH, Nevil C, Vasudeva R, Ali MF, Agasthya N. Treatment of Shiga-Toxin Hus with Severe Neurologic Features with Eculizumab. Case Reports in Pediatrics. 2021 Nov 13;2021:8053246. doi: 10.1155/2021/8053246. PMID: 34812294; PMCID: PMC8605924

Srivastava T, Joshi T, Heruth DP, Rezaiekhaligh MH, Garola RE, Zhou J, Boinpelly VC, Ali MF, Alon US, Sharma M, Vanden Heuvel GB, Mahajan P, Priya L, Jiang Y, McCarthy ET, Savin VJ, Sharma R, Sharma M. A mouse model of prenatal exposure to Interleukin-6 to study the developmental origin of health and disease. Scientific Reports. 2021 Jun 24;11(1):13260. doi: 10.1038/s41598-021-92751-6. PMID: 34168254; PMCID: PMC8225793

Srivastava T, Heruth DP, Duncan RS, Rezaiekhaligh MH, Garola RE, Priya L, Zhou J, Boinpelly VC, Novak J, Ali MF, Joshi T, Alon US, Jiang Y, McCarthy ET, Savin VJ, Sharma R, Johnson ML, Sharma M. Transcription Factor β-Catenin Plays a Key Role in Fluid Flow Shear Stress-Mediated Glomerular Injury in Solitary Kidney. Cells. 2021 May 19;10(5):1253. doi: 10.3390/cells10051253. PMID: 34069476; PMCID: PMC8159099

Ali MF, Venkatarayappa SKB, Benny M, Rojas C, Yousefi K, Shehadeh LA, Kulandavelu S, Sharma M, Da Silva N, Freundlich M, Abitbol CL, DeFreitas MJ, Young KC. Effects of Klotho supplementation on hyperoxia- induced renal injury in a rodent model of postnatal nephrogenesis. Pediatric Research. 2020 Oct;88(4):565-570. doi: 10.1038/s41390-020-0803-z. Epub 2020 Feb 14. PMID: 32059229; PMCID: PMC8226112